Often these genes have been targeted because of studies that detected phenotypic defects in humans resulting from mutations, as is the case with genes associated with vocalizations (e.g., dysphasia and dyspraxia resulting from mutations in FOXP2) and hearing (e.g., non-syndromic deafness resulting from mutations in hearing genes). The gene discussed is FOXP2; the disease is apraxia.